SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently trending as investors focus on its post-quantum cryptography features and recent institutional developments, including its classification as a digital commodity. While the community remains deeply divided between long-term holders citing technological utility and skeptics reacting to extended price consolidation, discussion is heavily driven by recent Google research citations and strategic moves toward real-world asset tokenization.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as the community rallies around its long-standing presence on the Solana network, emphasizing its inclusion on the Jupiter strict list and active engagement through community poker events. Supporters are highlighting the token's resilience after years of operation while actively promoting it across social channels to sustain its visibility among other trending meme coins.

APE fuels culture. Backed by the best club in the world and hundreds of thousands of holders worldwide, it’s the token for digital and IRL communities, builders, creators, collectors, gamers, and beyond.  APE is the native gas token of ApeChain and is available across multiple ecosystems including Ethereum, Arbitrum, Solana and HyperLiquid.z  ApeCoin's mission is is to supercharge its ecosystem by supporting high-quality builders &amp; reinforcing 3 core pillars: ApeChain, Bored Ape Yacht Club, and Otherside.

ApeCoin

ApeCoin is seeing a surge in investor attention as market sentiment shifts toward a potential crypto bull cycle and anticipation builds for continued network utility and ecosystem growth. The community is actively debating the token's long-term viability, with many closely watching volume spikes and technical resistance levels for signs of a parabolic trend.

The Sandbox is a community-driven platform where creators can monetize voxel ASSETS and gaming experiences on the blockchain.  SAND is the utility token used throughout The Sandbox ecosystem as the basis of transactions and interactions. It is an ERC-20 utility token built on the Ethereum blockchain. There is a finite supply of 3,000,000,000 SAND.

The Sandbox

The Sandbox is seeing renewed investor interest as gaming tokens heat up, fueled by a broader crypto market revival and anticipation of a metaverse resurgence. Community members are actively discussing potential price appreciation, drawing parallels to historical bull cycles while focusing on the project's long-standing partnerships and ecosystem development as key indicators for future performance.

Index Coop is a decentralized autonomous organization (DAO) that builds structured DeFi products and strategy tokens. Index Coop offers a suite of sector index products, leverage and inverse products, and yield-generating products. The product suite runs on Set Protocol, an audited, self-custodial DeFi tool that allows for the creation and management of Ethereum-based (or ERC-20) tokens. Changes to the DAO are voted on by the owners of a governance token called INDEX and then implemented by a team of developers. INDEX holders wield voting power on a 1:1 basis, meaning one token equals one vote.

Index Cooperative

Index Cooperative is seeing a surge in community engagement and speculation regarding its potential as a low-float asset primed for significant volatility, with many users drawing parallels to previous market cycles. Community discussions are heavily focused on the low circulating supply and its historical tendency for rapid price swings, while some participants debate the long-term utility of the governance token and its role in upcoming decentralized finance product expansions.

Polygon

Polygon is trending as investors debate whether the network's high transaction volume and adoption in stablecoin payments justify its current market performance or signal a deep undervaluation. The community remains polarized, with some bulls aggressively accumulating, citing the shift to the 'Open Money Stack' and payment-focused infrastructure, while others express frustration over continued price stagnation and concerns about dilution.

VeChain, founded in 2015, is a sustainability-focused blockchain driving mass adoption of Web3. Its energy-efficient VeChainThor chain delivers fast, low-cost transactions, making blockchain accessible to millions worldwide. With partnerships including UFC, BCG, and Walmart, and over 2 million active users on VeBetter-powered apps, VeChain is proving real-world impact at scale.  In 2024, the VeChain Renaissance upgrade was launched, introducing Ethereum compatibility, dPoS consensus, and dynamic gas fees. It cut VTHO inflation and introduced StarGate NFT staking, where users lock VET to mint transferable NFTs that earn VTHO, can be delegated to validators, and serve as governance instruments. The upgrade also added new eco node tiers, lowering entry barriers while keeping rewards across higher staking levels.  By combining adoption, upgraded tokenomics, and inclusive staking, VeChain is positioning itself as a leading blockchain where usage, growth, and rewards fuel long-term value creation.

Vechain

VeChain is trending as the community debates its long-term viability amid ongoing price stagnation and concerns over treasury management versus the project's extensive corporate and regulatory partnerships. While some investors are actively accumulating and pointing to upcoming protocol upgrades and supply chain utility as catalysts, others remain deeply frustrated by the asset's poor performance relative to the broader crypto market.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as investors weigh significant clinical catalysts, including upcoming Phase 3 data and potential FDA updates, against a high level of short interest that has fueled aggressive community debate over a possible short squeeze. While some traders are focused on the stock's volatility and the prospect of a major rebound, others remain cautious, debating the long-term impact of recent capital raises and the broader outlook for the gene-editing sector.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ remains a focal point for income-focused investors who are actively debating its performance relative to peers like QQQI and SPYI, especially as the community balances tech-heavy growth potential against the consistency of monthly distributions. Conversations are heavily concentrated on dividend capture strategies and the long-term role of the ETF within retirement portfolios, with many investors debating the tax implications of these distributions in taxable versus tax-advantaged accounts.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Equity Premium Income ETF

JPMorgan Equity Premium Income ETF

JPMorgan's JEPI and JEPQ are seeing heavy community interest due to their consistent monthly cash flow and defensive structure, which many investors are using to navigate current market volatility. While some participants discuss recent dividend distribution amounts and the role of covered call overlays in stabilizing portfolios, the community remains divided between those prioritizing long-term income accumulation and those concerned about the impact of market fluctuations on net asset value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tandem Diabetes Care, Inc. $TNDM Position Lowered by Paradice Investment Management LLC

Paradice Investment Management LLC decreased its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 5.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,077,745 shares of the me...

KBC Group NV Lowers Holdings in Tandem Diabetes Care, Inc. $TNDM

KBC Group NV lessened its stake in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 99.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and...

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Brokerages

Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Get Free Report) has received a consensus recommendation of "Hold" from the nineteen brokerages that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, nine have assign...

The Goldman Sachs Group Lowers Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $25.00

The Goldman Sachs Group lowered their price objective on shares of Tandem Diabetes Care from $28.00 to $25.00 and set a "neutral" rating on the stock in a research report on Thursday...

Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM). In a filing disclosed on April 07th, the Representative disclosed that they had bought between $1,001 and $15,000 in Tandem Diabetes Care stock on March 3rd. The trade...

JPMorgan Chase & Co. Sells 203,183 Shares of Tandem Diabetes Care, Inc. $TNDM

JPMorgan Chase & Co. lowered its position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) by 36.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 359,071 shares of the medical device company's stock after...

Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2026 results after the financial markets close on Thursday...

Tandem Diabetes Care (NASDAQ:TNDM) Trading Down 6.6% - Time to Sell?

Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Down 6.6% - Time to Sell...

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Analysts

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Get Free Report) have been assigned a consensus rating of "Hold" from the nineteen analysts that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, nine have issued a hold recommenda...

Assenagon Asset Management S.A. Invests $26.99 Million in Tandem Diabetes Care, Inc. $TNDM

Assenagon Asset Management S.A. purchased a new position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM - Free Report) during the fourth quarter, according to the company in its most recent filing with...

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

TNDM
Tandem Diabetes Care Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TNDM News

TNDMTandem Diabetes Care Inc